Rapid Respiratory Pathogen Detection
The Respiratory Pathogen Panel is a molecular diagnostic test that simultaneously identifies viral and bacterial nucleic acids (DNA or RNA) from a wide range of respiratory pathogens using a single patient sample, typically collected via nasopharyngeal swab. This approach enables rapid, accurate detection of multiple organisms—such as influenza, RSV, SARS-CoV-2, and atypical bacteria—helping clinicians differentiate causes of respiratory illness and tailor treatment decisions quickly and effectively.
Respiratory co-infections—where multiple pathogens are present simultaneously—are more common than often assumed, particularly in pediatric, elderly, or immunocompromised populations. Multiplex molecular panels like RPP can detect viral and bacterial pathogens in one test, including those that are difficult or slow to culture, such as RSV or atypical bacteria. Rapid and accurate detection of co-infections supports appropriate isolation, reduces unnecessary antibiotic use, and enables more precise clinical decision-making.
Elite Clinical Laboratory delivers RPP results with rapid turnaround and clinically actionable clarity. Our reports list all detected pathogens in an easy-to-read format and highlight co-infection scenarios that may affect treatment planning. We also offer interpretation support to guide clinicians in choosing appropriate therapies, adjusting infection control measures, and avoiding unnecessary interventions based on a complete pathogen profile.